20. November 2009 23:40
Bristol-Myers Squibb Company and Otsuka Pharmaceutical Co., Ltd. announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental New Drug Application (sNDA) for ABILIFY® (aripiprazole) for the treatment of irritability associated with autistic disorder in pediatric patients ages 6 to 17 years, including symptoms of aggression towards others, deliberate self-injuriousness, temper tantrums, and quickly changing moods.
[More]
eb34af81-8141-4574-b270-52cb5d01cd03|0|.0
Posted in: Child Health News | Pharmaceutical News
Tags: Abilify, Antidepressant, Antipsychotic, Autism, Bipolar Disorder, Blood Pressure, Cardiovascular Disease, Cell, Cerebrovascular Disease, Constipation, Creatinine, Dehydration, Dementia, Depression, Diabetes, Diabetes Mellitus, Dystonia, Exercise, Heart Failure, Hyperglycemia, Hypersensitivity, Insomnia, Leukopenia, Lipids, Nausea, Neutropenia, New Drug Application, Obesity, Pediatrics, Pneumonia, Psychosis, Schizophrenia, Speech, Stroke, Tardive Dyskinesia, Urticaria, Vomiting
26. October 2009 01:10
Obese patients taking medications to lower their blood pressure and cholesterol levels are less likely to reach recommended targets for these cardiovascular disease risk factors than their normal weight counterparts, according to new research presented at the 2009 Canadian Cardiovascular Congress hosted by the Canadian Cardiovascular Society and the Heart and Stroke Foundation of Canada.
[More]
14. October 2009 02:14
Vanda Pharmaceuticals Inc. announced today that it has entered into an agreement with Novartis Pharma AG to commercialize and develop Fanapt(TM) (iloperidone), Vanda's anti-psychotic, in the U.S. and Canada. Fanapt(TM) was approved by the U.S. Food and Drug Administration on May 6, 2009 for the acute treatment of schizophrenia in adults.
[More]
186e3f3d-615d-48d4-b516-21d41fe4e2e5|0|.0
Posted in: Business / Finance | Pharmaceutical News
Tags: Amenorrhea, Antipsychotic, Blood Pressure, Cardiovascular Disease, Cell, Cerebrovascular Disease, Dementia, Diabetes, Diabetes Mellitus, Dopamine, Hyperglycemia, Impotence, Leukopenia, Nervous System, Neutropenia, Pneumonia, Psychosis, Renal Failure, Schizophrenia, Serotonin, Tardive Dyskinesia
8. October 2009 06:49
Louis R. Caplan, MD, Senior Neurologist at Beth Israel Deaconess Medical Center (BIDMC) and a leader in the treatment and research of strokes, has been elected an Honorary Member of the American Neurological Association (ANA). As the organization's highest honor, Honorary Membership is reserved for select individuals who have made unique contributions to neurology and neurological science throughout their careers.
[More]
1. October 2009 05:34
The National Institutes of Health has awarded Rush University Medical Center approximately $5.5 million in grants to study how epigenetic changes - chemical modifications to genes that result from diet, aging, stress, or environmental exposures - define and contribute to memory formation and cognitive decline. Results from the studies could profoundly alter the way the medical community understands, diagnoses, and treats Alzheimer's disease, according to the researchers.
[More]
6d1a904c-7f23-4243-a987-6f5958a8d8b2|0|.0
Posted in: Medical Science News | Medical Condition News
Tags: Acetylation, Alzheimer's Disease, Brain, Cell, Cerebrovascular Disease, Cognitive Function, Dementia, Diet, DNA, DNA Methylation, Health and Human Services, Hospital, Nursing, Pathology, Stress
28. September 2009 07:18
The National Institutes of Health has awarded Rush University Medical Center approximately $5.5 million in grants to study how epigenetic changes - chemical modifications to genes that result from diet, aging, stress, or environmental exposures - define and contribute to memory formation and cognitive decline. Results from the studies could profoundly alter the way the medical community understands, diagnoses, and treats Alzheimer's disease, according to the researchers.
[More]
ce4b32e5-8234-4f5c-968a-1c8d641c6d8d|0|.0
Posted in: Medical Research News | Medical Condition News
Tags: Acetylation, Alzheimer's Disease, Brain, Cell, Cerebrovascular Disease, Cognitive Function, Dementia, Diet, DNA, DNA Methylation, Health and Human Services, Hospital, Nursing, Stress
14. September 2009 07:51
Schering-Plough Corporation today reported final results of a SAPHRIS(R) (asenapine) long-term schizophrenia relapse prevention clinical study.
[More]
35333850-f570-4f9b-ae60-af8696a5ba30|0|.0
Posted in: Drug Trial News
Tags: Amenorrhea, Antipsychotic, Anxiety, Asenapine, Bipolar Disorder, Blood Pressure, Brain, Cardiovascular Disease, Cell, Cerebrovascular Disease, Dementia, Depression, Diabetes, Diabetes Mellitus, Dopamine, Heart Failure, Hyperglycemia, Impotence, Insomnia, Leukopenia, Nervous System, Neutropenia, Pneumonia, Psychiatry, Psychosis, Renal Failure, Schizophrenia, Sleep, Sycrest, Tardive Dyskinesia
11. September 2009 06:48
Edward Hospital announced today that it has established the Edward Neurosciences Institute in affiliation with the Northwestern Medical Faculty Foundation to bring the highest level of stroke care in the world to the west and southwest suburbs of Chicago.
[More]
2. September 2009 06:43
The KYOTO HEART Study, which took place in Japan between January 2004 and January 2009, shows that the addition of valsartan to conventional antihypertensive treatment to improve blood pressure control is associated with an improved cardiovascular outcome in Japanese hypertensive patients at high risk of CVD events.
[More]
15468174-be3d-48ab-91e3-13350fd8c986|0|.0
Posted in: Medical Research News | Medical Condition News
Tags: Angina, Angiotensin, Blood Pressure, Cerebrovascular Disease, Creatinine, Diabetes, Dialysis, Heart Failure, Metabolic Syndrome, Metabolism, Obesity, Renin, Smoking, Stroke, Thrombosis, Transient Ischemic Attack
2. September 2009 04:23
The KYOTO HEART Study, which took place in Japan between January 2004 and January 2009, shows that the addition of valsartan to conventional antihypertensive treatment to improve blood pressure control is associated with an improved cardiovascular outcome in Japanese hypertensive patients at high risk of CVD events.
[More]
f4a1ad45-0419-4523-8fdc-7dc3ecc44ec8|0|.0
Posted in: Medical Research News | Pharmaceutical News
Tags: Angina, Angiotensin, Blood Pressure, Cerebrovascular Disease, Creatinine, Diabetes, Dialysis, Heart Failure, Metabolic Syndrome, Metabolism, Obesity, Renin, Smoking, Stroke, Thrombosis, Transient Ischemic Attack
1. September 2009 01:48
Exposure to carbon monoxide, even at levels well below national limits, is associated with an increased risk of hospitalization for the elderly with heart problems, according to a study published today in Circulation: Journal of the American Heart Association.
[More]
17. June 2009 20:57
Patients treated for Hodgkin lymphoma with radiation therapy have a substantially higher risk of stroke, according to a new study published June 17 online in the Journal of the National Cancer Institute.
[More]
16. June 2009 02:39
The skin disease psoriasis is associated with atherosclerosis (a buildup of plaque in the arteries) characterized by an increased prevalence of ischemic heart disease, cerebrovascular disease, peripheral artery disease and an increased risk of death, according to a report in the June issue of Archives of Dermatology.
[More]
0c285205-e951-490e-b310-da1cad3ee2cd|0|.0
Posted in: Medical Research News
Tags: Atherosclerosis, Cerebrovascular Disease, Diabetes, Dyslipidemia, Heart Attack (Myocardial Infarction), Hypertension (High Blood Pressure), Ischaemic Stroke, Lupus, Peripheral Arterial Disease, Peripheral Artery Disease, Psoriasis, Veterans Affairs
12. May 2009 17:07
An analysis of previous studies indicates that among patients with peripheral artery disease, aspirin use is associated with a statistically nonsignificant decrease in the risk of a group of combined cardiovascular events (nonfatal heart attack, nonfatal stroke, and cardiovascular death), but is associated with a significant reduction in the risk of one of these events, nonfatal stroke, although the findings may be limited by the lack of a large study population, according to an article in the May 13 issue of JAMA, the Journal of the American Medical Association.
[More]
12. May 2009 07:44
Sinobiopharma, Inc. has announced that it has received approval from the Chinese State Food and Drug Administration (SFDA) to manufacture and market its formulation of Perindopril, an anti-hypertension drug.
[More] 
Subscribe